Demonstration of Chlamydophila pneumoniae, Mycoplasma pneumoniae, cytomegalovirus, and Epstein-Barr virus in atherosclerotic coronary arteries, nonrheumatic calcific aortic and rheumatic stenotic mitral valves by polymerase chain reaction;Aterosklerotik koroner arterler, romatizmal olmayan kalsifik aort ve romatizmal stenotik mitral kapaklarda Chlamydophila pneumoniae, Mycoplasma pneumoniae, cytomegalovirus ve Epstein-Barr virüsün polimeraz zincir reaksiyonu ile gösterilmesi

Anadolu Kardiyoloji Dergisi

Volumn 11, Issue 3, 2011, Pages 237-243

  Bayram, Ayşen ^a   Erdoǧan, Mustafa Bilge ^b   Ekşi, Fahriye ^a   Yamak, Birol ^b  

^a GAZIANTEP UNIVERSITY   (Turkey)

^b Clinic of Cardiovascular Surgery   (Turkey)

Author keywords

Aortic valve; Atherosclerosis; Chlamydophila pneumoniae; Coronary artery; Cytomegalovirus; Epstein Barr virus; Mitral valve; Mycoplasma pneumoniae

Indexed keywords

ADULT; AGED; AORTA STENOSIS; AORTA VALVE REPLACEMENT; ARTERY CALCIFICATION; ARTICLE; BACTERIUM DETECTION; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BYPASS GRAFT; CROSS-SECTIONAL STUDY; CYTOMEGALOVIRUS; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REPLACEMENT; MITRAL VALVE STENOSIS; MYCOPLASMA PNEUMONIAE; POLYMERASE CHAIN REACTION; RHEUMATIC HEART DISEASE; VIRUS DETECTION;

ADOLESCENT; ADULT; AGED; AORTIC VALVE; AORTIC VALVE STENOSIS; CALCINOSIS; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; CORONARY ARTERY DISEASE; CORONARY VESSELS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE; MITRAL VALVE STENOSIS; MYCOPLASMA PNEUMONIAE; PNEUMONIA, MYCOPLASMA; POLYMERASE CHAIN REACTION; RHEUMATIC HEART DISEASE; YOUNG ADULT;

EID: 79956275095     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: 10.5152/akd.2011.057     Document Type: Article

References (52)

1. Radke PW, Merkelbach-Bruse S, Messmer BJ, vom Dahl J, Dörge H, Naami A, et al. Infectious agents in coronary lesions obtained by endatherectomy: pattern of distribution, coinfection, and clinical findings. Coron Artery Dis 2001; 12: 1-6.
2. Nyström-Rosander C, Thelin S, Hjelm E, Lindquist O, Påhlson C, Friman G. High incidence of Chlamydia pneumoniae in sclerotic heart valves of patients undergoing aortic valve replacement. Scand J Infect Dis 1997; 29: 361-5.
3. Juvonen J, Laurila A, Juvonen T, Aläkarppä H, Surcel HM, Lounatmaa K, et al. Detection of Chlamydia pneumoniae in human nonrheumatic stenotic aortic valves. J Am Coll Cardiol 1997; 29: 1054-9.
4. Juvonen J, Juvonen T, Laurila A, Kuusisto J, Alarakkola E, Särkioja T, et al. Can degenerative aortic valve stenosis be related to persistent Chlamydia pneumoniae infection. Ann Intern Med 1998; 128: 741-4.
5. Radke PW, Ortlepp JR, Merkelbach-Bruse S, Messmer BJ, Kaiser A, Kronenberger S, et al. Prevalence of cytomegalovirus in nonrheumatic stenotic aortic valves. Am J Cardiol 2002; 89: 477-9.
6. Skowash D, Schrempf S, Lentini S, Welsch U, Likungu JA, Preusse CJ, et al. Chlamydia pneumoniae and cytomegalovirus in degenerative aortic valve stenoses. Z Kardiol 2002; 91: 290-6.
7. Kaden JJ, Bickelhaupt S, Grobholz R, Brueckmann M, Haase KK, Dempfle CE, et al. Pathogenetic role of Chlamydia pneumoniae in calcific aortic stenosis: immunohistochemistry study and review of the literature. J Heart Valve Dis 2003; 12: 447-53.
8. Nyström-Rosander C, Lindh U, Ilback NG, Hjelm E, Thelin S, Lindqvist O, et al. Interactions between Chlamydia pneumoniae and trace elements: a possible link to aortic valve sclerosis. Biol Trace Elem Res 2003; 91: 97-110.
9. Nilsson K, Liu A, Pahlson C, Lindquist O. Demonstration of intracellular microorganisms (Rickettsia spp., Chlamydia pneumoniae, Bartonella spp.) in pathological human aortic valves by PCR. J Infect 2005; 50: 46-52.
10. Higuchi-Dos-Santos MH, Pierri H, Higuchi Mde L, Nussbacher A, Palomino S, Sambiase NV, et al. Chlamydia pneumoniae and Mycoplasma pneumoniae in calcified nodes of stenosed aortic valves. Arq Bras Cardiol 2005; 84: 443-8.
11. Pierri H, Higuchi-dos-Santos MH, Higuchi Mde L, Palomino S, Sambiase NV, Demarchi LM, et al. Density of Chlamydia pneumoniae is increased in fibrotic and calcified areas of degenerative aortic stenosis. Int J Cardiol 2006; 108: 43-7.
12. Rajamannan NM, Bonow RO, Rahimtoola SH. Calcific aortic stenosis: an update. Nat Clin Pract Cardiovasc Med 2007; 4: 254-62.
13. Yavuz T, Özaydi{dotless}n M, Ulusan V, Öcal A, İbrişim E, Kutsal A. A case of mitral stenosis complicated with seronegative Brucella endocarditis. Jpn Heart J 2004; 45: 353-8.
14. Roychoudhury D, Chaithiraphan V, Stathopoulos IA, Fergus I, Tortolani A, Murkis MA, et al. Culture-negative suppurative endocarditis causing severe mitral valve obstruction: complementary use of transesophageal and transthoracic echocardiography. Echocardiography 2003; 20: 429-34.
15. Pavlovic M, Berdat P, Holzer B, Aebi C, Carrel T, Pfammatter JP. Severe mitral valve involvement in a child with hypereosinophilia secondary to parasitic infection. J Heart Valve Dis 2003; 12: 649-51.
16. Kouchoukos NT, Blackstone EH, Doty DB, Hanley FL, Karp RB, editors. Aortic valve disease. Kirklin/Barratt-Boyes Cardiac Surgery. 3rd ed. Philadelphia: Churchill Livingstone; 2003.
17. Kouchoukos NT, Blackstone EH, Doty DB, Hanley FL, Karp RB, editors. Mitral valve disease with or without tricuspid valve disease. Kirklin/Barratt-Boyes Cardiac Surgery. 3rd ed. Philadelphia: Churchill Livingstone; 2003.
18. Reszka E, Jegier B, Wasowicz W, Lelonek M, Banach M, Jaszewski R. Detection of infectious agents by polymerase chain reaction in human aortic wall. Cardiovasc Pathol 2008; 17: 297-302.
19. Shi Y, Tokunaga O. Herpesvirus (HSV-1, EBV and CMV) infections in atherosclerotic compared with non-atherosclerotic aortic tissue. Pathol Int 2002; 52: 31-9.
20. Ibrahim AI, Obeid MT, Jouma MJ, Moasis GA, Al-Richane WL, Kindermann I, et al. Detection of herpes simplex virus, cytomegalovirus and Epstein-Barr virus DNA in atherosclerotic plaques and in unaffected bypass grafts. J Clin Virol 2005; 32: 29-32.
21. Paradowska E, Przepiórkiewicz M, Nowakowska D, Studzinska M, Wilczynski J, Emery VC, et al. Detection of cytomegalovirus in human placental cells by polymerase chain reaction. APMIS 2006; 114: 764-71.
22. Yamamoto M, Kimura H, Hironaka T, Hirai K, Hasegawa S, Kuzushima K, et al. Detection and quantification of virus DNA in plasma of patients with Epstein-Barr virus-associated diseases. J Clin Microbiol 1995; 33: 1765-8.
23. Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O'Brien KD. Characterization of the early lesions of "degenerative" valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 1994; 90: 844-53.
24. Olsson M, Dalsgaard CJ, Haegerstrand A, Rosenqvist M, Rydén L, Nilsson J. Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves. J Am Coll Cardiol 1994; 23: 1162-70.
25. Turgeman Y, Levahar P, Lavi I, Shneor A, Colodner R, Samra Z, et al. Adult calcific aortic stenosis and Chlamydia pneumoniae: the role of Chlamydia infection in valvular calcification. Isr Med Assoc J 2006; 8: 464-8.
26. Mohler ER 3rd, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS. Bone formation and inflammation in cardiac valves. Circulation 2001; 103: 1522-8.
27. Ieven MM, Hoymans VY. Involvement of Chlamydia pneumoniae in atherosclerosis: more evidence for lack of evidence. J Clin Microbiol 2005; 43: 19-24.
28. Goldenberger D, Kunzli A, Vogt P, Zbinden R, Altwegg M. Molecular diagnosis of bacterial endocarditis by broad-range PCR amplification and direct sequencing. J Clin Microbiol 1997; 35: 2733-9.
29. Rassu M, Cazzavillan S, Scagnelli M, Peron A, Bevilacqua PA, Facco M, et al. Demonstration of Chlamydia pneumoniae in atherosclerotic arteries from various vascular regions. Atherosclerosis 2001; 158: 73-9.
30. Latsios G, Saetta A, Michalopoulos NV, Agapitos E, Patsouris E. Detection of cytomegalovirus, Helicobacter pylori and Chlamydia pneumoniae DNA in carotid atherosclerotic plaques by polymerase chain reaction. Acta Cardiol 2004; 59: 652-7.
31. Kakli{dotless}kkaya I, Kakli{dotless}kkaya N, Buruk K, Pulathan Z, Koramaz I, Aydi{dotless}n F, et al. Investigation of Chlamydia pneumoniae DNA, Chlamydial lipopolysaccharide antigens, and Helicobacter pylori DNA in atherosclerotic plaques of patients with aortoiliac occlusive disease. Cardiovasc Pathol 2006; 15: 105-9.
32. Farsak B, Yi{dotless}ldi{dotless}ri{dotless}r A, Akyön Y, Pi{dotless}nar A, Öç M, Böke E, et al. Detection of Chlamydia pneumoniae and Helicobacter pylori DNA in human atherosclerotic plaques by PCR. J Clin Microbiol 2000; 38: 4408-11.
33. Shi Y, Tokunaga O. Chlamydia pneumoniae and multiple infections in the aorta contribute to atherosclerosis. Pathol Int 2002; 52: 755-63.
34. Campbell LA, Kuo CC. Chlamydia pneumoniae-an infectious risk factor for atherosclerosis? Nat Rev Microbiol 2004; 2: 23-32.
35. Daus H, Özbek C, Saage D, Scheller B, Schieffer H, Pfreundschuh M, et al. Lack of evidence for a pathogenic role of Chlamydia pneumoniae and cytomegalovirus infection in coronary atheroma formation. Cardiology 1998; 90: 83-8.
36. Apfalter P, Barousch W, Nehr M, Willinger B, Rotter M, Hirschl AM. No evidence of involvement of Chlamydia pneumoniae in severe cerebrovascular atherosclerosis by means of quantitative realtime polymerase chain reaction. Stroke 2004; 35: 2024-8.
37. Watt S, Aesch B, Lanotte P, Tranquart F, Quentin R. Viral and bacterial DNA in carotid atherosclerotic lesions. Eur J Clin Microbiol Infect Dis 2003; 22: 99-105.
38. Hagiwara N, Toyoda K, Inoue T, Shimada H, Ibayashi S, Iida M, et al. Lack of association between infectious burden and carotid atherosclerosis in Japanese patients. J Stroke Cerebrovasc Dis 2007; 16: 145-52.
39. Odeh M, Oliven A Chlamydial infections of the heart. Eur J Clin Microbiol Infect Dis 1992; 11: 885-93.
40. Hendrix MGR, Salimans MM, van Boven CP, Bruggeman CA. High prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am J Pathol 1990; 136: 23-8.
41. Stassen FR, Vega-Cordova X, Vliegen I, Bruggeman CA. Immune activation following cytomegalovirus infection: more important than direct viral effects in cardiovascular disease? J Clin Microbiol 2006; 35: 349-53.
42. Saetta A, Fanourakis G, Agapitos E, Davaris PS. Atherosclerosis of the carotid artery: absence of evidence for CMV involvement in atheroma formation. Cardiovasc Pathol 2000; 9: 181-3.
43. Pi{dotless}nar A, Öç M, Akyön Y, Farsak B, Koçyi{dotless}ldi{dotless}ri{dotless}m E, Us D, et al. The presence of Chlamydophila pneumoniae, Helicobacter pylori and cytomegalovirus in human atherosclerosis detected by molecular and serological methods. Mikrobiyol Bul 2004; 38: 213-22.
44. Xenaki E, Hassoulas J, Apostolakis S, Sourvinos G, Spandidos DA. Detection of cytomegalovirus in atherosclerotic plaques and nonatherosclerotic arteries. Angiology 2009; 60: 504-8.
45. Kennedy JH, Henrion D, Wassef M, Bloch G, Tedgui A. Cytomegalovirus in calcific aortic stenosis. Am Heart J 2001; 141: E4.
46. Horvath R, Cerny J, Benedik J Jr, Hokl J, Jelinkova I, Benedik J. The possible role of human cytomegalovirus (HCMV) in the origin of atherosclerosis. J Clin Virol 2000; 16: 17-24.
47. Tanaka S, Komori K, Okadome K, Sugimachi K, Mori R. Detection o active cytomegalovirus infection in inflammatory aortic aneurysms with RNA polymerase chain reactin. J Vasc Surg 1994; 20: 235-43.
48. Know TW, Kim DK, Ye JS, Lee WJ, Moon MS, Joo CH, et al. Detection of enterovirus, cytomegalovirus, and Chlamydia pneumoniae in atheromas. J Microbiol 2004; 42: 299-304.
49. Vahanian A, Iung B, Pierard D, Pepper J. Heart valve disease. In: Camm AJ, Lüscher TF, Serruys PW, editors. The ESC Textbook of Cardiovascular Medicine. 1st editors. Oxford: Blackwell Publishing: 2006. p. 626.
50. Skowasch D, Tuleta I, Steinmetz M, Pabst S, Preusse CJ, Welz A, et al. Pathogen burden in degenerative aortic valves is associated with inflammatory and immune reactions. J Heart Valve Dis 2009; 18: 411-7.
51. Palta S, Pai AM, Gill KS, Pai RG. New insights into the progression of calcific aortic stenosis: implications for secondary prodression. Circulation 2000; 101: 2497-502.
52. Sessa R, Nicoletti M, Di Pietro M, Schiavoni G, Santino I, Zagaglia C, et al. Chlamydia pneumoniae and atherosclerosis: current state and future perspectives. Int J Immunopathol Pharmacol 2009; 22: 9-14.